Bristol-Myers Squibb
BMY
BMY
2,280 hedge funds and large institutions have $76.3B invested in Bristol-Myers Squibb in 2025 Q2 according to their latest regulatory filings, with 151 funds opening new positions, 816 increasing their positions, 1,027 reducing their positions, and 308 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
22% less capital invested
Capital invested by funds: $97.3B → $76.3B (-$21B)
51% less first-time investments, than exits
New positions opened: 151 | Existing positions closed: 308
56% less funds holding in top 10
Funds holding in top 10: 36 → 16 (-20)
Holders
2,280
Holding in Top 10
16
Calls
$1.12B
Puts
$1.26B
Top Buyers
| 1 | +$533M | |
| 2 | +$500M | |
| 3 | +$479M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$450M |
| 5 |
Man Group
London,
United Kingdom
|
+$270M |
Top Sellers
| 1 | -$553M | |
| 2 | -$442M | |
| 3 | -$383M | |
| 4 |
Bank of New York Mellon
New York
|
-$295M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$265M |